Lisa Larkin, MD, FACP, MSCP, IF - Advancing Menopause Management: Integrating Neurokinin-Targeted Therapies for Vasomotor Symptoms

episode

CME in Minutes: Education in Primary Care not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

Press Pass | Lawrence on Prep for Patriots' Run Defense, Responding & Building Trust 11 min · 23 Sep 2026 · The Jacksonville Jaguars Official Podcast Network

Iran Enters the War of Words; The AI Agenda for the Trump-Xi Summit 26 min · 23 Sep 2026 · Here's the Scoop

Trump vs. the media 21 min · 23 Sep 2026 · The NPR Politics Podcast

Trump meets Xi: what's at stake? 19 min · 23 Sep 2026 · Business Daily

Musings About the Agentic Future 22 min · 23 Sep 2026 · Motley Fool Hidden Gems Investing

The Reign of Spain 54 min · 23 Sep 2026 · Football Daily

Report any issue

Source

Recorded01 Oct 2025

Publisherc.answersincme.com ↗

Handlerec:10296214

Show notes

Please visit answersincme.com/VYT860 to participate, download slides and supporting materials, complete the post test, and obtain credit. In this activity, an expert in women’s health discusses the management of vasomotor symptoms (VMS) associated with menopause. Upon completion of this activity, participants should be better able to: Identify VMS as a consequence of menopause; Evaluate the efficacy and safety of new and emerging neurokinin (NK)-targeted therapies for VMS; Implement shared decision-making for optimal VMS treatment outcomes

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in